Fin
Echo
Markets
Dashboard
Search
Fear & Greed
Tools
Watchlist
Budget
Context
Upcoming
Notifications
Upcoming
Research
News
Market Events
Economy
New
SEC Filings
Finecho Content
New
Fin
Echo
Markets
Dashboard
Search
Fear & Greed
Tools
Watchlist
Budget
Context
Upcoming
Notifications
Upcoming
Research
News
Market Events
Economy
New
SEC Filings
Finecho Content
New
HAVILAND KATE
Private
CIK: 1663022
Location
CAMBRIDGE, MA
Insider Of
4
Name & Role
Position
Tenure
Holdings
FULCRUM THERAPEUTICS, INC.
—
Since Jul 2019
—
BLUEPRINT MEDICINES CORP
Chief Operating Officer
Since Mar 2019
—
BICARA THERAPEUTICS INC.
—
Since Sep 2024
—
AVALYN PHARMA INC.
—
Since Apr 2026
—
FULCRUM THERAPEUTICS, INC.
Position
—
Tenure
Since Jul 2019
Holdings
—
BLUEPRINT MEDICINES CORP
Position
Chief Operating Officer
Tenure
Since Mar 2019
Holdings
—
BICARA THERAPEUTICS INC.
Position
—
Tenure
Since Sep 2024
Holdings
—
AVALYN PHARMA INC.
Position
—
Tenure
Since Apr 2026
Holdings
—